"I wouldn't be surprised if COURAGE, as designed, is a negative trial, " Gregg Stone, director of cardiovascular research and education at Columbia University Medical Center, said two weeks ago.

FORBES: Magazine Article

"I wouldn't be surprised if COURAGE, as designed, is a negative trial, " says Gregg Stone, director of cardiovascular research and education at Columbia University Medical Center, who has conducted major clinical trials of Boston Scientific's stent.

FORBES: Magazine Article

"Everything we do is a balance of risks and benefits for the infant, and we have to be vigilant to make sure we are not making things worse, " says Dan L. Ellsbury, director of the Center for Research, Education and Quality at Pediatrix Medical Group, a large neonatal physicians group and a unit of Mednax Inc.

WSJ: How Hospitals Save More Lives and Reduce Infections in Premature Babies